Colgate-Palmolive (NYSE:CL) Shares Purchased by Davis R M Inc.

Davis R M Inc. boosted its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 7.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 196,367 shares of the company’s stock after acquiring an additional 14,351 shares during the quarter. Davis R M Inc.’s holdings in Colgate-Palmolive were worth $17,852,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in CL. Kohmann Bosshard Financial Services LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at $32,000. OFI Invest Asset Management acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at $36,000. Finally, Bernard Wealth Management Corp. acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at $36,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $97.46 on Tuesday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a market capitalization of $79.09 billion, a price-to-earnings ratio of 27.69, a P/E/G ratio of 4.20 and a beta of 0.40. The stock’s fifty day simple moving average is $88.97 and its 200-day simple moving average is $95.06.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business earned $0.87 EPS. On average, sell-side analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.05%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on CL shares. UBS Group lowered their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. TD Cowen lowered their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Raymond James reiterated an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Finally, Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $101.61.

Get Our Latest Report on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.